Biotech Holders Trust Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
Moderna ETFs To Shine On Vaccine News As Outbreak Worsens
Article By: Zacks Investment Research
Wednesday, November 18, 2020 4:55 AM EST
The first company to begin human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has once again come up with encouraging study data relating to mRNA-1273.
In this article: IBB, BBH, XBI, BTEC, IDNA, GERM, MRNA
Read
Will Novavax ETFs Gain On Coronavirus Vaccine Progress?
Article By: Zacks Investment Research
Saturday, September 5, 2020 5:50 PM EST
Novavax (NVAX) is a formidable name in the list of companies who are working on a vaccine. The company’s shares have gained 2487.4% this year. Let’s look at ETFs with the highest exposure to Novarax that can gain on the positive development,
In this article: BBH, PTH, IBB, DWAS, GERM
Read
Moderna ETFs To Gain On New Positive COVID-19 Vaccine Data
Article By: Zacks Investment Research
Friday, August 28, 2020 6:31 PM EST
The competition to come up with a coronavirus vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.
In this article: IBB, BBH, XBI, MRNA, CNCR, BTEC, IDNA, GERM
Read
Biotech ETFs To Gain As Coronavirus Vaccine Hopes Strengthen
Article By: Zacks Investment Research
Sunday, July 5, 2020 1:58 PM EST
The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to the biotech sector:
In this article: IBB, BBH, FBT, XBI, ARKG Also: AZN, JNJ, PFE, MRNA
Read
Moderna - A Step Closer To Coronavirus Vaccine: ETFs To Gain
Article By: Zacks Investment Research
Sunday, June 14, 2020 3:44 PM EST
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.
In this article: AZN, JNJ, BBH, MRNA, CNCR, IDNA Also: IBB, XBI
Read

Latest Tweets for $BBH

No tweets yet!